Mitch DeKoven

1.2k total citations
86 papers, 929 citations indexed

About

Mitch DeKoven is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Economics and Econometrics. According to data from OpenAlex, Mitch DeKoven has authored 86 papers receiving a total of 929 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Epidemiology, 16 papers in Endocrinology, Diabetes and Metabolism and 14 papers in Economics and Econometrics. Recurrent topics in Mitch DeKoven's work include Diabetes Treatment and Management (12 papers), Health Systems, Economic Evaluations, Quality of Life (11 papers) and Influenza Virus Research Studies (10 papers). Mitch DeKoven is often cited by papers focused on Diabetes Treatment and Management (12 papers), Health Systems, Economic Evaluations, Quality of Life (11 papers) and Influenza Virus Research Studies (10 papers). Mitch DeKoven collaborates with scholars based in United States, United Kingdom and Netherlands. Mitch DeKoven's co-authors include Victoria Divino, Won Chan Lee, Stephen I. Pelton, J Mould-Quevedo, Maarten J. Postma, Swapna Karkare, Girishanthy Krishnarajah, David L. Cooper, Thomas Wısnıewskı and J Langer and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Mitch DeKoven

77 papers receiving 907 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mitch DeKoven United States 20 234 219 131 123 108 86 929
Mauro Boronat Spain 20 849 3.6× 249 1.1× 127 1.0× 407 3.3× 49 0.5× 66 1.3k
Hana Fakhoury Saudi Arabia 16 56 0.2× 130 0.6× 299 2.3× 105 0.9× 25 0.2× 71 1.2k
C Cave United Kingdom 11 195 0.8× 236 1.1× 89 0.7× 83 0.7× 9 0.1× 14 792
Jason Yeaw United States 12 217 0.9× 113 0.5× 32 0.2× 78 0.6× 39 0.4× 37 847
Gi Hyeon Seo South Korea 18 313 1.3× 140 0.6× 68 0.5× 228 1.9× 14 0.1× 59 859
Gary G. Singer United States 13 58 0.2× 346 1.6× 143 1.1× 518 4.2× 117 1.1× 22 1.8k
Paras Karmacharya United States 22 42 0.2× 100 0.5× 85 0.6× 206 1.7× 193 1.8× 81 1.3k
D. L. Economides United Kingdom 30 137 0.6× 229 1.0× 208 1.6× 652 5.3× 304 2.8× 68 2.8k
Carrie R. Wong United States 16 49 0.2× 367 1.7× 40 0.3× 517 4.2× 73 0.7× 30 1.3k
Luc J. J. Derijks Netherlands 22 27 0.1× 366 1.7× 112 0.9× 205 1.7× 178 1.6× 65 1.5k

Countries citing papers authored by Mitch DeKoven

Since Specialization
Citations

This map shows the geographic impact of Mitch DeKoven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitch DeKoven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitch DeKoven more than expected).

Fields of papers citing papers by Mitch DeKoven

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitch DeKoven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitch DeKoven. The network helps show where Mitch DeKoven may publish in the future.

Co-authorship network of co-authors of Mitch DeKoven

This figure shows the co-authorship network connecting the top 25 collaborators of Mitch DeKoven. A scholar is included among the top collaborators of Mitch DeKoven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitch DeKoven. Mitch DeKoven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Donovan, Fariba, Mark Bresnik, Belinda Lovelace, et al.. (2025). Antifungal therapy patterns, healthcare utilization, costs, and mortality in central nervous system and non-central nervous system disseminated coccidioidomycosis across the continuum-of-care. Clinical Microbiology and Infection. 31(6). 1046–1052. 1 indexed citations
2.
Morlock, Robert, Deepan Dalal, Victoria Divino, et al.. (2024). Characteristics and Management of Uncontrolled Gout Prior to Pegloticase Therapy: A 2-year Claims Analysis. Rheumatology and Therapy. 12(1). 37–51.
3.
Newson, Rachel S., Victoria Divino, Kristina S. Boye, et al.. (2024). Glycemic Control and Obesity Among People With Type 2 Diabetes in Europe and Australia: A Retrospective Cohort Analysis. Diabetes Therapy. 15(6). 1435–1449. 3 indexed citations
4.
Dreyfus, Jill, Swapna Munnangi, Camilla Bengtsson, et al.. (2024). Background incidence rates of health outcomes in populations at risk for Lyme disease using US administrative claims data. Vaccine. 42(5). 1094–1107.
6.
Doshi, Riddhi, et al.. (2024). Payer approval and rejection of oral anticoagulant prescriptions and prescription abandonment patterns among patients with venous thromboembolism. Journal of Managed Care & Specialty Pharmacy. 30(5). 441–455. 1 indexed citations
7.
Mount, Julie, et al.. (2023). Obesity and Glycemic Control in People with Type 2 Diabetes in Germany: A Retrospective Cohort Analysis. Diabetologie und Stoffwechsel. 18(S 01). S27–S27.
8.
Hüll, Michael, et al.. (2023). Health care resource utilization and costs among patients with spasticity or cervical dystonia. Journal of Managed Care & Specialty Pharmacy. 30(1). 86–97. 3 indexed citations
9.
Hüll, Michael, et al.. (2023). Botulinum Toxin Utilization, Treatment Patterns, and Healthcare Costs Among Patients with Spasticity or Cervical Dystonia in the US. Advances in Therapy. 40(9). 3986–4003. 3 indexed citations
10.
Loftus, Jane, Bradley S. Miller, Craig S. Parzynski, et al.. (2022). Association of Daily Growth Hormone Injection Adherence and Height Among Children With Growth Hormone Deficiency. Endocrine Practice. 28(6). 565–571. 21 indexed citations
14.
Pelton, Stephen I., Maarten J. Postma, Victoria Divino, et al.. (2020). PIN3 RELATIVE VACCINE EFFECTIVENESS OF QUADRIVALENT CELL-BASED VERSUS EGG-BASED INFLUENZA VACCINES AMONG ADULTS 50-64 YEARS OLD: A U.S. OBSERVATIONAL COHORT STUDY. Value in Health. 23. S168–S168. 2 indexed citations
17.
Divino, Victoria, et al.. (2016). Pharmaceutical expenditure on drugs for rare diseases in Canada: a historical (2007–13) and prospective (2014–18) MIDAS sales data analysis. Orphanet Journal of Rare Diseases. 11(1). 68–68. 13 indexed citations
18.
Divino, Victoria, et al.. (2016). Generic Drug Volume and Cost Savings in Oncology: A 2005-2014 Midas Analysis. Value in Health. 19(7). A753–A754.
19.
Mehta, Samir, et al.. (2015). Low-intensity pulsed ultrasound (LIPUS) can decrease the economic burden of fracture non-union. Journal of Medical Economics. 18(7). 542–549. 15 indexed citations
20.
Anderson, Karen E., Victoria Divino, Mitch DeKoven, et al.. (2014). Interventional Differences Among Huntington's Disease Patients by Disease Progression in Commercial and Medicaid Populations. Journal of Huntington s Disease. 3(4). 355–363. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026